Renalytix AI Launches Global Offering Of Its Shares

(Alliance News) - Diagnostics company Renalytix AI PLC on Monday said it is commencing an ...

Alliance News 13 July, 2020 | 8:02PM
Email Form

(Alliance News) - Diagnostics company Renalytix AI PLC on Monday said it is commencing an underwritten offering of 11.0 million of its shares.

The offer includes a registered public offering of shares in the form of American depositary shares in the US and a concurrent private placement of shares in Europe and other countries outside of the US.

In addition, Renalytix AI said it intends to grant the underwriters a 30-day option to purchase additional American depositary shares in an aggregate amount of up to 15% of the total number of American depositary shares proposed to be sold in the offering.

Investors other than qualified investors under applicable law will not be eligible to participate in the private placement, Renalytix AI noted.

Renalytix AI said it has applied to have its American depositary shares listed on the Nasdaq Global Market, while it said it will maintain its AIM listing alongside the Nasdaq dual-listing.

JP Morgan and Stifel are acting as joint global coordinators and joint book-running managers for the Global Offering.

Renalytix shares closed 2.1% higher in London on Monday at 581.70 pence each.

By Evelina Grecenko;

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Renalytix AI PLC 615.50 GBX 3.45 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies